NEU 6.17% $19.02 neuren pharmaceuticals limited

Analysts giving Neu EPS of $1.20With Phase 2 trails x 3 more...

  1. 2,162 Posts.
    lightbulb Created with Sketch. 536
    Analysts giving Neu EPS of $1.20

    With Phase 2 trails x 3 more indications this year to drop with opportunity x 5 of our current asset generating this EPS Time for the P/E ratio to lift to x 30 or beyond to be serious EPS $1.20 x 30 P/E = $36


    https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=newssearch&cd=&cad=rja&uact=8&ved=2ahUKEwiC-aLhg96EAxUGRmcHHdjfBYkQxfQBKAB6BAgPEAE&url=https%3A%2F%2Ffinance.yahoo.com%2Fnews%2Fneuren-pharmaceuticals-limited-just-missed-003422559.html&usg=AOvVaw1mdxRxdO7R5kr26WM-3YUI&opi=89978449
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.02
Change
-1.250(6.17%)
Mkt cap ! $2.428B
Open High Low Value Volume
$20.40 $20.50 $18.82 $19.92M 1.034M

Buyers (Bids)

No. Vol. Price($)
3 1652 $19.00
 

Sellers (Offers)

Price($) Vol. No.
$19.03 11612 4
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
$19.10
  Change
-1.250 ( 6.19 %)
Open High Low Volume
$20.39 $20.46 $18.83 299764
Last updated 15.59pm 04/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.